On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Granzer Heinz Ulrich's own share of each project, not the project's full budget.
- Horizon Europe€489k · 2 projects
- Horizon 2020€267k · 1 project
Projects
3 EU-funded projects, newest first. Each links to the official record.
- NEXGEN-PDPartner
Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€101ktheir share - XVR011 Phase 2Partner
ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2
Horizon Europe · 2021–2022 · Project on CORDIS ↗
€388ktheir share - IMMUNISAPartner
A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€267ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- Vib vzwBelgium · 1 shared project
- Philipps Universitaet MarburgGermany · 1 shared project
- Paracelsus Medizinische Privatuniversitat Salzburg - PrivatstiftungAustria · 1 shared project
- Exevir BioBelgium · 1 shared project
- Millipore SASFrance · 1 shared project
- Inc Research UK LtdUnited Kingdom · 1 shared project
- Modus Research and Innovation LimitedUnited Kingdom · 1 shared project
- PNO Life Sciences & Health B.V.Netherlands · 1 shared project
- Tridem Bioscience GmbH & Co KGAustria · 1 shared project
- European Cancer Patient CoalitionBelgium · 1 shared project
- Institute for Medical Technology Assessment BVNetherlands · 1 shared project
- Isa Therapeutics BVNetherlands · 1 shared project
- Aurigon Labs Zartkoruen Mukodo ReszvenytarsasagHungary · 1 shared project
- Motac FranceFrance · 1 shared project
- Austrian Red Cross Research GmbHAustria · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- DNA viruses
- cervical cancer
- entrepreneurship
- immunotherapy
- pandemics
- pathology
- proteins
- surgery
- vaccines
- virology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.